| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/02/2014 | US8822471 Compounds, pharmaceutical compositions and uses thereof |
| 09/02/2014 | US8822470 Substituted pyrido[2,3-b]pyrazines |
| 09/02/2014 | US8822469 Pyrrolo[2,3-B]pyrazines useful as inhibitors of ATR kinase |
| 09/02/2014 | US8822468 3-Methyl-imidazo[1,2-b]pyridazine derivatives |
| 09/02/2014 | US8822467 Biaryl oxyacetic acid compounds |
| 09/02/2014 | US8822465 Quinoline compound composing 1,2,4-triazine-dione and use thereof |
| 09/02/2014 | US8822464 N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors |
| 09/02/2014 | US8822462 Subunit selective NMDA receptor potentiators for the treatment of neurological conditions |
| 09/02/2014 | US8822461 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use |
| 09/02/2014 | US8822460 Fused cyclopentyl antagonists of CCR2 |
| 09/02/2014 | US8822459 Compound containing basic group and use thereof |
| 09/02/2014 | US8822458 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/02/2014 | US8822456 Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds |
| 09/02/2014 | US8822455 Fused aminodihydrothiazine derivatives |
| 09/02/2014 | US8822454 Bisfluoroalkyl-1,4-benzodiazepinone compounds |
| 09/02/2014 | US8822453 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation |
| 09/02/2014 | US8822451 Modulators of ATP-binding cassette transporters |
| 09/02/2014 | US8822450 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections |
| 09/02/2014 | US8822449 Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 09/02/2014 | US8822447 Indazole compounds useful as ketohexokinase inhibitors |
| 09/02/2014 | US8822446 Pyrrolopyridine inhibitors of kinases |
| 09/02/2014 | US8822445 Crystalline form of carbapenem derivative or its hydrates and preparation methods and uses thereof |
| 09/02/2014 | US8822444 Hepatitis C virus inhibitors |
| 09/02/2014 | US8822443 Solid herbicidal composition |
| 09/02/2014 | US8822442 Somatostatin-dopamine chimeric analogs |
| 09/02/2014 | US8822441 Ecdysterone synthesis derivative, preparation method and use thereof |
| 09/02/2014 | US8822440 Inhibiting cyclin D polypeptides |
| 09/02/2014 | US8822439 Glucocorticoid receptor agonists |
| 09/02/2014 | US8822438 Methods and compositions for treating cancer |
| 09/02/2014 | US8822437 Cerebral nerve cell neogenesis agent |
| 09/02/2014 | US8822436 Compositions for oral administration of zoledronic acid or related compounds for treating disease |
| 09/02/2014 | US8822435 Bisphosphonate compounds |
| 09/02/2014 | US8822434 Compositions and methods to treat cardiac diseases |
| 09/02/2014 | US8822433 Complex combining an organic silicon derivative with hyaluronic and acid calibrated fragments, for preventive and repairing action of cutaneous damages |
| 09/02/2014 | US8822432 Equol production accelerating composition |
| 09/02/2014 | US8822431 Methods of treating optic disorders |
| 09/02/2014 | US8822430 Antiviral compounds |
| 09/02/2014 | US8822429 Citicoline for the treatment of glaucoma and ocular hypertension |
| 09/02/2014 | US8822427 Methods and compositions to protect aquatic invertebrates from disease |
| 09/02/2014 | US8822424 Antibacterial aminoglycoside analogs |
| 09/02/2014 | US8822422 Antitumor agent |
| 09/02/2014 | US8822421 E2F as a target of hormone refractory prostate cancer |
| 09/02/2014 | US8822415 Cellular-factor containing solution compositions |
| 09/02/2014 | US8822414 Heterocyclic compounds suitable for the treatment of dyslipidemia |
| 09/02/2014 | US8822410 Tympanic membrane permeating ear drops and uses thereof |
| 09/02/2014 | US8822225 Method of calculating a phosphorus-protein ratio |
| 09/02/2014 | US8822169 HMG1 antibody for treating inflammatory conditions |
| 09/02/2014 | US8821944 Polymorph compositions, methods of making, and uses thereof |
| 09/02/2014 | US8821943 Methods and compositions for targeted delivery of therapeutic agents |
| 09/02/2014 | US8821939 Bioactive agent delivery particles |
| 09/02/2014 | US8821938 Porous drug matrices and methods of manufacture thereof |
| 09/02/2014 | US8821936 Solid pharmaceutical formulation |
| 09/02/2014 | US8821935 Microcapsules with modified release of active principles with low solubility for oral delivery |
| 09/02/2014 | US8821934 Pullulan-containing powder, process for producing the same and use thereof |
| 09/02/2014 | US8821932 Pharmaceutical compositions |
| 09/02/2014 | US8821930 Modified release preparations containing oxcarbazepine and derivatives thereof |
| 09/02/2014 | US8821929 Tamper resistant dosage forms |
| 09/02/2014 | US8821927 Pharmaceutical composition |
| 09/02/2014 | US8821926 Tablet containing hardly soluble active ingredient |
| 09/02/2014 | US8821923 Using bucky paper as a therapeutic aid in medical applications |
| 09/02/2014 | US8821921 Vitamin D3 for the transdermal treatment of pain and inflammation |
| 09/02/2014 | US8821920 Therapeutic patch for transdermal delivery of capsaicin |
| 09/02/2014 | US8821915 Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
| 09/02/2014 | US8821914 Non-abusable pharmaceutical composition comprising opioids |
| 09/02/2014 | US8821913 Controlled releases system containing temozolomide |
| 09/02/2014 | US8821910 Alkylaminoalkyl oligomers as broad-spectrum antimicrobial agent |
| 09/02/2014 | US8821906 Biocompatible polymer |
| 09/02/2014 | US8821904 Topical composition and use thereof for the prophylaxis and the treatment of defects connected to inflammatory dermopathies |
| 09/02/2014 | US8821899 Method and process for the production of multi-coated recognitive and releasing systems |
| 09/02/2014 | US8821898 Active compound combinations having insecticidal and acaricidal properties |
| 09/02/2014 | US8821896 Purified Plasmodium and vaccine composition |
| 09/02/2014 | US8821877 Methods for inhibiting HIV-1 replication involving the administration of an anti-CCR5 receptor monoclonal antibody and small molecule CCR5 receptor antagonist |
| 09/02/2014 | US8821873 Treatment of diffuse large-cell lymphoma with anti-CD20 antibody |
| 09/02/2014 | US8821850 Protein-polymer-drug conjugates |
| 09/02/2014 | US8821849 Internal clamp for surgical procedures |
| 09/02/2014 | US8821848 Ferrate and povidone iodine (PI) composition |
| 09/02/2014 | US8821838 Nanoparticulate compositions for diagnostic imaging |
| 09/02/2014 | US8821548 Spine distraction implant and method |
| 09/02/2014 | US8821473 Methods and compositions to treat myocardial conditions |
| 09/02/2014 | US8820323 Methods to administer formulations of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
| 09/02/2014 | CA2776702C Topical dapsone for the treatment of acne |
| 09/02/2014 | CA2776242C Phenyloxadiazole derivatives as pgds inhibitors |
| 09/02/2014 | CA2693644C Chitosan carboxyalkylamide hydrogel, preparation thereof and cosmetic and dermatological use thereof |
| 09/02/2014 | CA2651128C Benzimidazole modulators of vr1 |
| 09/02/2014 | CA2645488C Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions |
| 09/02/2014 | CA2642952C Pharmaceutical composition comprising oseltamivir phosphate |
| 09/02/2014 | CA2602467C Bcrp/abcg2 inhibitor |
| 09/02/2014 | CA2586443C 5-hydroxy-benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 09/02/2014 | CA2578549C Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer |
| 09/02/2014 | CA2532229C Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 08/28/2014 | WO2014131023A1 Neoseptins: small molecule adjuvants |
| 08/28/2014 | WO2014130992A1 Methods and agents for preventing and treating plasma cell dyscrasias |
| 08/28/2014 | WO2014130947A1 Pyrazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 08/28/2014 | WO2014130945A1 Modifications for antisense compounds |
| 08/28/2014 | WO2014130922A1 Compositions and methods for treating fungal infections |
| 08/28/2014 | WO2014130910A1 Treatment for substance use disorders and stress disorders |
| 08/28/2014 | WO2014130908A1 Methods for treatment of ophthalmic diseases and disorders |
| 08/28/2014 | WO2014130894A1 Compositions for the treatment of inflammatory diseases |
| 08/28/2014 | WO2014130869A1 Gamma-diketones as wnt/beta -catenin signaling pathway activators |
| 08/28/2014 | WO2014130856A2 Treatment of skeletal-related disorders |